Literature DB >> 25043060

HIV: The mixed blessing of interferon.

Amalio Telenti1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25043060     DOI： 10.1038/nature13517

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  14 in total

1.  Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial.

Authors:  David M Asmuth; Robert L Murphy; Susan L Rosenkranz; Juan J L Lertora; Shyam Kottilil; Yoninah Cramer; Ellen S Chan; Robert T Schooley; Charles R Rinaldo; Nathan Thielman; Xiao-Dong Li; Sharon M Wahl; Jessica Shore; Jennifer Janik; Richard A Lempicki; Yaa Simpson; Richard B Pollard
Journal:  J Infect Dis       Date:  2010-06-01       Impact factor: 5.226

Review 2.  Disease tolerance as a defense strategy.

Authors:  Ruslan Medzhitov; David S Schneider; Miguel P Soares
Journal:  Science       Date:  2012-02-24       Impact factor: 47.728

Review 3.  The restriction factors of human immunodeficiency virus.

Authors:  Reuben S Harris; Judd F Hultquist; David T Evans
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

4.  Malignancies in the AIDS patient: natural history, treatment strategies, and preliminary results.

Authors:  D L Longo; R G Steis; H C Lane; M T Lotze; S A Rosenberg; O Preble; H Masur; A H Rook; A S Fauci; J Jacob
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

5.  Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys.

Authors:  Steven E Bosinger; Qingsheng Li; Shari N Gordon; Nichole R Klatt; Lijie Duan; Luoling Xu; Nicholas Francella; Abubaker Sidahmed; Anthony J Smith; Elizabeth M Cramer; Ming Zeng; David Masopust; John V Carlis; Longsi Ran; Thomas H Vanderford; Mirko Paiardini; R Benjamin Isett; Don A Baldwin; James G Else; Silvija I Staprans; Guido Silvestri; Ashley T Haase; David J Kelvin
Journal:  J Clin Invest       Date:  2009-12       Impact factor: 14.808

6.  Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals.

Authors:  Margalida Rotger; Kristen K Dang; Jacques Fellay; Erin L Heinzen; Sheng Feng; Patrick Descombes; Kevin V Shianna; Dongliang Ge; Huldrych F Günthard; David B Goldstein; Amalio Telenti
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

Review 7.  Regulation of type I interferon responses.

Authors:  Lionel B Ivashkiv; Laura T Donlin
Journal:  Nat Rev Immunol       Date:  2014-01       Impact factor: 53.106

8.  Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.

Authors:  Francesca J Torriani; Maribel Rodriguez-Torres; Jürgen K Rockstroh; Eduardo Lissen; Juan Gonzalez-García; Adriano Lazzarin; Giampiero Carosi; Joseph Sasadeusz; Christine Katlama; Julio Montaner; Hoel Sette; Sharon Passe; Jean De Pamphilis; Frank Duff; Uschi Marion Schrenk; Douglas T Dieterich
Journal:  N Engl J Med       Date:  2004-07-29       Impact factor: 91.245

9.  HIV and innate immunity - a genomics perspective.

Authors:  Antonio Rausell; Paul J McLaren; Amalio Telenti
Journal:  F1000Prime Rep       Date:  2013-08-01

10.  Relative resistance of HIV-1 founder viruses to control by interferon-alpha.

Authors:  Angharad E Fenton-May; Oliver Dibben; Tanja Emmerich; Haitao Ding; Katja Pfafferott; Marlen M Aasa-Chapman; Pierre Pellegrino; Ian Williams; Myron S Cohen; Feng Gao; George M Shaw; Beatrice H Hahn; Christina Ochsenbauer; John C Kappes; Persephone Borrow
Journal:  Retrovirology       Date:  2013-12-03       Impact factor: 4.602
View more
  7 in total

1.  TLR7 dosage polymorphism shapes interferogenesis and HIV-1 acute viremia in women.

Authors:  Pascal Azar; José Enrique Mejía; Claire Cenac; Arnoo Shaiykova; Ali Youness; Sophie Laffont; Asma Essat; Jacques Izopet; Caroline Passaes; Michaela Müller-Trutwin; Pierre Delobel; Laurence Meyer; Jean-Charles Guéry
Journal:  JCI Insight       Date:  2020-06-18

2.  Interferon Alpha Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8+ T Cells.

Authors:  Abena K R Kwaa; Chloe A G Talana; Joel N Blankson
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

3.  HIV-1 Env and Nef Cooperatively Contribute to Plasmacytoid Dendritic Cell Activation via CD4-Dependent Mechanisms.

Authors:  Natalia J Reszka-Blanco; Vijay Sivaraman; Liguo Zhang; Lishan Su
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

4.  Identification of potential HIV restriction factors by combining evolutionary genomic signatures with functional analyses.

Authors:  Paul J McLaren; Ali Gawanbacht; Nitisha Pyndiah; Christian Krapp; Dominik Hotter; Silvia F Kluge; Nicola Götz; Jessica Heilmann; Katharina Mack; Daniel Sauter; Danielle Thompson; Jérémie Perreaud; Antonio Rausell; Miguel Munoz; Angela Ciuffi; Frank Kirchhoff; Amalio Telenti
Journal:  Retrovirology       Date:  2015-05-16       Impact factor: 4.602

5.  Emergence of CXCR4-tropic HIV-1 variants followed by rapid disease progression in hemophiliac slow progressors.

Authors:  Tsunefusa Hayashida; Kiyoto Tsuchiya; Yoshimi Kikuchi; Shinichi Oka; Hiroyuki Gatanaga
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

Review 6.  Sex Differences in Primary HIV Infection: Revisiting the Role of TLR7-Driven Type 1 IFN Production by Plasmacytoid Dendritic Cells in Women.

Authors:  Jean-Charles Guéry
Journal:  Front Immunol       Date:  2021-08-27       Impact factor: 7.561

7.  Reducing IRF-1 to Levels Observed in HESN Subjects Limits HIV Replication, But Not the Extent of Host Immune Activation.

Authors:  Ruey-Chyi Su; Andrew Plesniarski; Zhujun Ao; Joshua Kimani; Aida Sivro; Walter Jaoko; Frank A Plummer; Xiaojian Yao; Terry Blake Ball
Journal:  Mol Ther Nucleic Acids       Date:  2015-10-27       Impact factor: 10.183
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.